ATAI Life Sciences N.V [NASDAQ: ATAI] closed the trading session at $2.25.
The stocks have a year to date performance of 69.17 percent and weekly performance of 52.03 percent. The stock has been moved at 61.87 percent over the last six months. The stock has performed 40.62 percent around the most recent 30 days and changed 112.26 percent over the most recent 3-months.
If compared to the average trading volume of 1.90M shares, ATAI reached to a volume of 12666750 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about ATAI Life Sciences N.V [ATAI]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ATAI shares is $7.80 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ATAI stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for ATAI Life Sciences N.V shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 18, 2024. The new note on the price target was released on April 03, 2024, representing the official price target for ATAI Life Sciences N.V stock. Previously, the target price had yet another raise to $18, while Loop Capital analysts kept a Buy rating on ATAI stock.
The Average True Range (ATR) for ATAI Life Sciences N.V is set at 0.19, with the Price to Sales ratio for ATAI stock in the period of the last 12 months amounting to 1144.09. The Price to Book ratio for the last quarter was 2.59, with the Price to Cash per share for the same quarter was set at 0.60.
ATAI stock trade performance evaluation
ATAI Life Sciences N.V [ATAI] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 52.03. With this latest performance, ATAI shares gained by 40.62% in over the last four-week period, additionally plugging by 61.87% over the last 6 months – not to mention a rise of 24.31% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ATAI stock in for the last two-week period is set at 75.26, with the RSI for the last a single of trading hit 81.71, and the three-weeks RSI is set at 70.54 for ATAI Life Sciences N.V [ATAI]. The present Moving Average for the last 50 days of trading for this stock 1.5100, while it was recorded at 1.7500 for the last single week of trading, and 1.4500 for the last 200 days.
ATAI Life Sciences N.V [ATAI]: An insightful look at the core fundamentals
ATAI Life Sciences N.V’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.81 and a Current Ratio set at 5.81.
ATAI Life Sciences N.V [ATAI]: Institutional Ownership
There are presently around $26.70%, or 29.67%% of ATAI stock, in the hands of institutional investors. The top three institutional holders of ATAI stocks are: WALLEYE CAPITAL LLC with ownership of 2.76 million shares, which is approximately 1.7388%. MORGAN STANLEY, holding 2.72 million shares of the stock with an approximate value of $$3.62 million in ATAI stocks shares; and MORGAN STANLEY, currently with $$1.74 million in ATAI stock with ownership which is approximately 0.8225%.
